Stockreport

Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury

Aptinyx Inc.  (APTX) 
Last aptinyx inc. earnings: 3/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aptinyx.com/investors-media
PDF EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the t [Read more]